Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Ex-GSK, Novartis exec named as Mundipharma’s Head of Access

May 14, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment, pharma

Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access. Moreau has amassed …
Appointment
merck-keytruda

MSD’s Keytruda recommended on NHS in Scotland for Stage 3 melanoma

May 14, 2019 Manufacturing and Production, Sales and Marketing Cancer, MSD, Scotland, Scottish Medicines Consortium, keytruda, melanoma, pharma

MSD has revealed that Keytruda (pembrolizumab) will be made available to NHS Scotland patients after the Scottish Medicines Consortium (SMC) …
News
shutterstock_206748499

The interplay between the GDPR and the EU Clinical Trials Regulation

May 13, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GDPR, clinical trial data, clinical trials, eu clinical trials regulation, pharma, trial data

Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the …
Feature
shutterstock_87495637

UK GPs are underequipped to handle growing chronic opioid use, report warns

May 13, 2019 Medical Communications, Sales and Marketing NHS, UK, opioid crisis, opioids, pharma

New research from the University of East Anglia (UEA) has argued that general practitioners (GPs) in the UK are lacking …
News
hepatitis_a_virus_01

US sees 300% increase in the number of cases of Hepatitis A

May 13, 2019 Sales and Marketing CDC, hepatitis a, pharma, public health, sanitation

The number of Americans infected with Hepatitis A has increased 300% in the past three years, according to figures from …
News

Heart disease deaths increase for first time in 50 years

May 13, 2019 Sales and Marketing BHF, UK, cardiovascular, health, heart disease, obesity

Deaths from heart disease among people under the age of 75 have increased for the first time in 50 years. …
News
lilly_entrance_web

Lilly’s Cyramza approved in US for hepatocellular carcinoma sub-population

May 13, 2019 Sales and Marketing Eli Lilly, FDA, cyramza, hepatocellular carcinoma, pharma

Eli Lilly’s vascular endothelial growth factor (VEGF) receptor 2 antagonist Cyramza (ramucirumab) has received approval in the US as a …
News
teva_copy

US States allege 20 generic drugmakers fixed prices of generic drugs

May 13, 2019 Sales and Marketing competition, generics, markets, price fixing, price-fixing, pricing

Forty-four US States have filed a lawsuit against 20 generic drugmakers – including Teva Pharmaceuticals – over allegations the firms …
News
fda2outsideweb

FDA to end controversial “alternative summary reporting” of medical devices in bid to boost transparency

May 10, 2019 Medical Communications, Research and Development, Sales and Marketing FDA, US, adverse events, medical devices, pharma

The FDA has revealed that it plans to terminate its “alternative summary reporting” programme which has allowed the manufacturers of …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 10, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …
News
genentech_web

Ocrevus becomes first NICE-approved therapy on the NHS for primary progressive multiple sclerosis

May 9, 2019 Sales and Marketing Genentech, NHS, NICE, Ocrevus, UK

NICE has announced its final appraisal decision on Genentech’s Ocrevus (ocrelizumab), choosing to recommend the drug for use on the …
News
novartis_window

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

May 9, 2019 Business Services, Medical Communications, Sales and Marketing Novartis, Shire, Takeda, debt, pharma, xiidra

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal …
News
dupixentpackage

Sanofi’s Dupixent approved in Europe for severe asthma maintenance

May 9, 2019 Sales and Marketing Dupixent, EU, Europe, Sanofi, asthma, pharma

Sanofi has revealed that its interleukin-4 and interleukin-13 (IL-4 and IL-13) inhibitor Dupixent (dupilumab) has been awarded marketing approval by …
News
mohammed_dar

Mohammed Dar becomes third MedImmune exec to join Immunocore

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO. Dar …
Appointment
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026